Joan Lunden Discusses Her TNBC Diagnosis With Roy Firestone

Joan Lunden
Published: Thursday, Jan 22, 2015



Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.

Lunden recounts an interview with Susan M. Love, MD, where she discovered the need for ultrasound, as a result of her dense breast tissue. It was this revelation and procedure that greatly impacted the stage of disease at diagnosis and overall prognosis, Lunden states.

Joan Lunden will be delivering the keynote address at the 32nd Miami Breast Cancer Conference. To attend the meeting along with OncLive, register at gotoper.com.



Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.

Lunden recounts an interview with Susan M. Love, MD, where she discovered the need for ultrasound, as a result of her dense breast tissue. It was this revelation and procedure that greatly impacted the stage of disease at diagnosis and overall prognosis, Lunden states.

Joan Lunden will be delivering the keynote address at the 32nd Miami Breast Cancer Conference. To attend the meeting along with OncLive, register at gotoper.com.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x